HCAT
Health Catalyst Inc

812
Mkt Cap
$114.58M
Volume
1.54M
52W High
$5.06
52W Low
$1.56
PE Ratio
-1.06
HCAT Fundamentals
Price
$1.68
Prev Close
$1.62
Open
$1.59
50D MA
$2.17
Beta
1.66
Avg. Volume
1.03M
EPS (Annual)
-$1.15
P/B
0.36
Rev/Employee
$204,389.33
$435.77
Loading...
Loading...
News
all
press releases
Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates
Senseonics (SENS) delivered earnings and revenue surprises of -7.80% and +0.70%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7h ago
News Placeholder
More News
News Placeholder
Primecap Management Co. CA Sells 617,620 Shares of Health Catalyst, Inc. $HCAT
Primecap Management Co. CA cut its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 31.1% during the 3rd quarter, according to its most recent disclosure with the Securities...
MarketBeat·3d ago
News Placeholder
Talkspace, Inc. (TALK) Tops Q4 Earnings Estimates
Talkspace (TALK) delivered earnings and revenue surprises of +50.00% and -0.16%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·12d ago
News Placeholder
Health Catalyst Appoints Ben Albert as Chief Executive Officer
Health Catalyst Appoints Ben Albert as Chief Executive Officer Health Catalyst Appoints Ben Albert as Chief Executive Officer PR Newswire SALT LAKE CITY, Feb. 18, 2026 Albert to Sharpen Focus on...
PR Newswire·13d ago
News Placeholder
Health Catalyst (HCAT) to Release Earnings on Wednesday
Health Catalyst (NASDAQ:HCAT) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...
MarketBeat·13d ago
News Placeholder
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Hold" from Brokerages
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has earned a consensus rating of "Hold" from the fourteen analysts that are presently covering the company, Marketbeat Ratings reports. One...
MarketBeat·13d ago
News Placeholder
Health Catalyst (NASDAQ:HCAT) Trading Down 6% - Time to Sell?
Health Catalyst (NASDAQ:HCAT) Shares Down 6% - Here's What Happened...
MarketBeat·13d ago
News Placeholder
Down 20.4% in 4 Weeks, Here's Why Health Catalyst (HCAT) Looks Ripe for a Turnaround
Health Catalyst (HCAT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·15d ago
News Placeholder
Down 21.4% in 4 Weeks, Here's Why Health Catalyst (HCAT) Looks Ripe for a Turnaround
Health Catalyst (HCAT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·18d ago
News Placeholder
Here's Why Health Catalyst (HCAT) Is a Great 'Buy the Bottom' Stock Now
Health Catalyst (HCAT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks·1mo ago
<
1
2
...
>

Latest HCAT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.